China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

Publisher Name :
Date: 29-Jun-2019
No. of pages: 150

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IVD market has burgeoned due to robust demand over the years, with its size approximating RMB57.6 billion in 2018, an annualized jump of 19.3%.

Reagents now prevail in the Chinese IVD industry, sweeping over 70% of the total value of the industry. In the country, IVD reagents mainly include those for immunological, biochemical and molecular diagnostics, among which the first two kinds of diagnosis reagents are the mainstay of the industry, seizing a combined more than 60% shares.

In China, world-renowned big names such as Roche, Siemens, Abbott and Thermo Fisher are the main players in the high-end IVD market; local companies including Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shanghai Kehua Bio-Engineering Co., Ltd., Maccura Biotechnology Co., Ltd., Autobio Diagnostics Co., Ltd., Dirui Industrial Co., Ltd., Beijing Leadman Biochemistry Co., Ltd., MedicalSystem Biotechnology Co., Ltd. and Sinocare Inc., have gained a firm foothold in the low- and mid-end markets.

China has issued industrial policies to shore up local Chinese IVD companies since 2011, setting the stage for homemade products to replace the imported. Lower price and favorable policies are a boon for Chinese companies to break the monopoly of their foreign peers.

China’s IVD industry will head toward the following directions in the years to come:


  • Factors such as population aging, two-child policy and higher health budget will be conducive to the rising demand for IVD;

  • Frequent mergers and acquisitions will make the market more concentrated;

  • High-end immunological diagnostics, molecular diagnostics and point-of-care testing (POCT) will be three major trends.


The report highlights the following:


  • China IVD industry (development status, market size, market structure, competitive pattern and development trends);

  • China IVD market segments (development status, competitive pattern and development trends);

  • China IVD downstream sectors;

  • 6 foreign and 24 Chinese IVD companies (operation, gross margin, IVD business, development strategy, etc.).

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

Table of Contents

1 Overview
1.1 Definition
1.2 Classification

2 China In Vitro Diagnostic Industry
2.1 Development Status
2.2 Market Size
2.3 Market Structure
2.4 Competitive Pattern
2.5 Development Trends
2.5.1 Aging of Population Spurs IVD Industry
2.5.2 Higher Healthcare Expenditures are a Boon for IVD Industry
2.5.3 Government Backs IVD Industry
2.5.4 High-end Immunological Diagnostics, Molecular Diagnostics and POCT will be Three Major Trends
2.5.5 Related Companies Flock to Capital Market for Further Development
2.5.6 Implementation of Two-child Policy Fuels IVD Industry
2.5.7 Frequent Mergers and Acquisitions are Likely to Make IVD Market More Concentrated

3 China IVD Market Segments
3.1 Companion Diagnostics
3.1.1 Development Status
3.1.2 Market Structure
3.1.3 Market Size
3.1.4 Growth Drivers
3.1.5 Competitive Pattern
3.2 Immunological Diagnostics
3.2.1 Development Status
3.2.2 Competitive Pattern
3.2.3 Development Trends
3.3 Molecular Diagnostics
3.3.1 Development Status
3.3.2 Competitive Pattern
3.3.3 Development Trends
3.4 Biochemical Diagnostics
3.4.1 Development Status
3.4.2 Competitive Pattern
3.4.3 Development Trends
3.5 POCT
3.5.1 Development Status
3.5.2 Competitive Pattern
3.5.3 Development Trends

4 China IVD Downstream Sectors
4.1 Healthcare Sector
4.1.1 Number of Medical Institutions
4.1.2 Medical Services
4.1.3 Medical Income
4.2 Independent Clinical Laboratory Sector
4.2.1 Development Status
4.2.2 Market Size
4.2.3 Competitive Pattern
4.2.4 Development Trends

5 Major Foreign Companies
5.1 Roche
5.1.1 Profile
5.1.2 Operation
5.1.3 In Vitro Diagnostics Business
5.1.4 Development in China
5.2 Siemens
5.2.1 Profile
5.2.2 Operation
5.2.3 In Vitro Diagnostics Business
5.2.4 Development in China
5.3 Abbott
5.3.1 Profile
5.3.2 Operation
5.3.3 In Vitro Diagnostics Business
5.3.4 Development in China
5.4 Thermo Fisher
5.4.1 Profile
5.4.2 Operation
5.4.3 In Vitro Diagnostics Business
5.4.4 Development in China
5.5 Danaher
5.5.1 Profile
5.5.2 Operation
5.5.3 In Vitro Diagnostics Business
5.5.4 Development in China
5.6 Sysmex
5.6.1 Profile
5.6.2 Operation
5.6.3 In Vitro Diagnostics Business
5.6.4 Development in China

6 Major Chinese Companies
6.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
6.1.1 Profile
6.1.2 Operation
6.1.3 Gross Margin
6.1.4 In Vitro Diagnostics Business
6.1.5 Development Strategy
6.2 Autobio Diagnostics Co., Ltd.
6.2.1 Profile
6.2.2 Operation
6.2.3 Gross Margin
6.2.4 In Vitro Diagnostics Business
6.2.5 Development Strategy
6.3 Beijing Strong Biotechnologies, Inc.
6.3.1 Profile
6.3.2 Operation
6.3.3 Gross Margin
6.3.4 In Vitro Diagnostics Business
6.3.5 Development Strategy
6.4 MedicalSystem Biotechnology Co., Ltd.
6.4.1 Profile
6.4.2 Operation
6.4.3 Gross Margin
6.4.4 In Vitro Diagnostics Business
6.4.5 Development Strategy
6.5 DAAN Gene Co., Ltd. of Sun Yat-sen University
6.5.1 Profile
6.5.2 Operation
6.5.3 Gross Margin
6.5.4 In Vitro Diagnostics Business
6.5.5 Development Strategy
6.6 Beijing Leadman Biochemistry Co., Ltd.
6.6.1 Profile
6.6.2 Operation
6.6.3 Gross Margin
6.6.4 In Vitro Diagnostics Business
6.6.5 Development Strategy
6.7 Sinocare Inc.
6.7.1 Profile
6.7.2 Operation
6.7.3 Gross Margin
6.7.4 In Vitro Diagnostics Business
6.7.5 Development Strategy
6.8 Shanghai Kehua Bio-Engineering Co., Ltd.
6.8.1 Profile
6.8.2 Operation
6.8.3 Gross Margin
6.8.4 In Vitro Diagnostics Business
6.8.5 Development Strategy
6.9 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
6.9.1 Profile
6.9.2 Operation
6.9.3 Gross Margin
6.9.4 In Vitro Diagnostics Business
6.9.5 Development Strategy
6.10 Livzon Pharmaceutical Group Inc.
6.10.1 Profile
6.10.2 Operation
6.10.3 Gross Margin
6.10.4 In Vitro Diagnostics Business
6.10.5 Development Strategy
6.11 Maccura Biotechnology Co., Ltd.
6.11.1 Profile
6.11.2 Operation
6.11.3 Gross Margin
6.11.4 In Vitro Diagnostics Business
6.11.5 Development Strategy
6.12 Guangzhou Wondfo Biotech Co., Ltd.
6.12.1 Profile
6.12.2 Operation
6.12.3 Gross Margin
6.12.4 In Vitro Diagnostics Business
6.12.5 Development Strategy
6.13 Biosino Bio-Technology and Science Inc.
6.13.1 Profile
6.13.2 Operation
6.13.3 Gross Margin
6.13.4 In Vitro Diagnostics Business
6.13.5 Development Strategy
6.14 Jiangsu Bioperfectus Technologies Co., Ltd.
6.14.1 Profile
6.14.2 Operation
6.14.3 Gross Margin
6.14.4 In Vitro Diagnostics Business
6.14.5 Development Strategy
6.15 Zhejiang Orient Gene Biotech Co., Ltd.
6.15.1 Profile
6.15.2 Operation
6.15.3 Gross Margin
6.15.4 In Vitro Diagnostics Business
6.15.5 Development Strategy
6.16 HOB Biotech Group Suzhou Co., Ltd.
6.16.1 Profile
6.16.2 Operation
6.16.3 Gross Margin
6.16.4 In Vitro Diagnostics Business
6.16.5 Development Strategy
6.17 Lifotronic Technology Co., Ltd.
6.17.1 Profile
6.17.2 Operation
6.17.3 Gross Margin
6.17.4 In Vitro Diagnostics Business
6.17.5 Development Strategy
6.18 Hotgen Biotech Co., Ltd.
6.18.1 Profile
6.18.2 Operation
6.18.3 Gross Margin
6.18.4 In Vitro Diagnostics Business
6.18.5 Development Strategy
6.19 Dirui Industrial Co., Ltd.
6.19.1 Profile
6.19.2 Operation
6.19.3 Gross Margin
6.19.4 In Vitro Diagnostics Business
6.19.5 Development Strategy
6.20 Getein Biotech, Inc.
6.20.1 Profile
6.20.2 Operation
6.20.3 Gross Margin
6.20.4 In Vitro Diagnostics Business
6.20.5 Development Strategy
6.21 Guangdong Hybribio Biotech Co., Ltd.
6.21.1 Profile
6.21.2 Operation
6.21.3 Gross Margin
6.21.4 In Vitro Diagnostics Business
6.21.5 Development Strategy
6.22 Beijing Bohui Innovation Biotechnology Co., Ltd.
6.22.1 Profile
6.22.2 Operation
6.22.3 Gross Margin
6.22.4 In Vitro Diagnostics Business
6.22.5 Development Strategy
6.23 Edan Instruments, Inc.
6.23.1 Profile
6.23.2 Operation
6.23.3 Gross Margin
6.23.4 In Vitro Diagnostics Business
6.23.5 Development Strategy
6.24 Wuhan Easy Diagnosis Biomedicine Co., Ltd.
6.24.1 Profile
6.24.2 Operation
6.24.3 Gross Margin
6.24.4 In Vitro Diagnostics Business
6.24.5 Development Strategy

List of Charts

Classification of In Vitro Diagnosis
Classification of In Vitro Diagnostic Instruments
Classification of In Vitro Diagnostic Reagents
Global In Vitro Diagnostic Market Size, 2015-2018
Medical Instrument Market Size in China, 2013-2018
Development History of In Vitro Diagnostic Industry in China
In Vitro Diagnostic Market Size in China, 2009-2018
In Vitro Diagnostic Market Size in China, 2018-2025E
In Vitro Diagnostic Market Structure in China (by Type), 2018
In Vitro Diagnostic Market Structure in China (by Product), 2018
Competition Pattern of Diagnostic Reagent Industry in China
In Vitro Diagnostic Product Layout of Chinese In Vitro Diagnostic Companies
IVD Revenue of Major Diagnostic Reagent Enterprises in China, 2014-2018
IVD Market Share of Major Diagnostic Reagent Enterprises in China, 2014-2018
Population Aged over 60 in China, 2009-2018
Total Health Expenditure in China, 2010-2018
Policies on In Vitro Diagnostic Industry in China, 2012-2018
Development Prospects of In Vitro Diagnostic Market Segments in China
Development History of Companion Diagnostic Reagent Kits
Joint Launch History of Targeted Drugs and their Companion Diagnostic
Companion Diagnostic Reagents Approved by FDA for Marketing
Number of Companion Diagnostic Products Approved in the US (by Technology)
Market Share of Companion Diagnostic Reagents in the US (by Technology), 2018
Number of Companion Diagnostic Products Approved in the US (by Target)
Number of Companion Diagnostic Products Approved in the US (by Indication)
Market Share of Companion Diagnostic Reagents in the US (by Indication), 2018
Global Companion Diagnostic Market Size, 2016-2025E
Companion Diagnostic Market Size in China, 2016-2025E
FDA's Regulatory History of Companion Diagnostic Reagents
Companion Diagnostic Coverage of Major Insurance Companies in the US
Merits and Demerits of Different Companion Diagnostic Business Models
Comparison between Five Immunodiagnostic Technologies
Chemiluminescence Diagnostic Market Share in China, 2018
Chemiluminescence Diagnosis VS Enzyme-linked Immunodiagnosis
Comparison between Main Technologies Applied to Molecular Diagnostics
Market Share of Molecular Diagnostic Enterprises in China, 2018
NGS-based Tumor Diagnostic Reagent Kits of Local Chinese Enterprises in Special Approval Procedures for Innovative Medical Instruments
Financing Cases in China’s Gene Sequencing Industry, 2017-2018
Categories of Biochemical Diagnostic Reagents
Categories of Biochemical Diagnostic Systems in China
Market Share of Biochemical Diagnostic Enterprises in China, 2018
Applied Scenarios and Fields of POCT Products
Comparison between POCT and Clinical Laboratory Diagnosis
Market Share of POCT Enterprises in China, 2018
Layout of Chinese Enterprises in POCT
Potential POCT Market Size in China
Number of Medical and Health Institutions in China, 2015-2019
Number of Hospitals in China, 2009-2019
Number of Hospitals in China by Economic Type, 2009-2019
Clinic Visits of Medical Institutions in China, 2015-2019
Clinic Visits of Hospitals in China, 2009-2019
Clinic Visits of Hospitals in China by Economic Type, 2012-2019
Total Revenue of Medical and Health Institutions in China, 2010-2018
Total Revenue of Medical and Health Institutions in China, 2018-2025E
Total Revenue of Hospitals in China, 2009-2018
Comparison of Independent Clinical Laboratory Market Penetration between China, Europe, America and Japan, 2018
Comparison of Diagnostic Item Quantity among Various Medical Institutions
Independent Clinical Laboratory Market Size in China, 2010-2018
Number of Independent Clinical Laboratories in China, 2007-2018
Independent Clinical Laboratory Revenue of Main Independent Clinical Laboratory Enterprises in China, 2014-2018
Marker Share of Independent Clinical Laboratory Enterprises in China, 2018
Comprehensive Comparison between Leading Independent Clinical Laboratory Enterprises in China, 2018
Independent Clinical Laboratory Market Size and YoY Growth in China, 2018-2025E
Policies on Public Hospital Reform in China, 2015-2019
Number of Private Hospitals and YoY Growth in China, 2009-2018
Clinic Visits of Private Hospitals in China, 2012-2018
Population Aged over 60 in China, 2009-2018
Market Share of Kingmed Diagnostics, 2014-2018
Revenue and Net Income of Roche, 2013-2018
Revenue Structure of Roche by Product, 2013-2018
IVD Revenue of Roche, 2013-2018
Revenue and Net Income of Siemens, 2013-2018
Revenue Structure of Siemens by Product, 2013-2018
IVD Revenue of Siemens, 2013-2018
Revenue and Net Income of Abbott, 2013-2018
Revenue Structure of Abbott by Product, 2013-2018
IVD Revenue of Abbott, 2013-2018
Revenue and Net Income of Thermo Fisher, 2013-2018
Revenue Structure of Thermo Fisher by Product, 2013-2018
IVD Revenue of Thermo Fisher, 2013-2018
Revenue and Net Income of Danaher, 2013-2018
Revenue Structure of Danaher by Product, 2013-2018
IVD Revenue of Danaher, 2013-2018
Revenue and Net Income of Sysmex, 2013-2018
Revenue Structure of Sysmex by Product, 2013-2018
IVD Revenue of Sysmex, 2013-2018
Revenue and Net Income of Shenzhen Mindray Bio-Medical Electronics, 2013-2018
Revenue Structure of Shenzhen Mindray Bio-Medical Electronics by Product, 2013-2018
Gross Margin of Shenzhen Mindray Bio-Medical Electronics, 2013-2018
IVD Revenue of Shenzhen Mindray Bio-Medical Electronics, 2013-2018
Revenue and Net Income of Autobio Diagnostics, 2013-2018
Revenue Structure of Autobio Diagnostics by Product, 2013-2018
Gross Margin of Autobio Diagnostics, 2013-2018
IVD Revenue of Autobio Diagnostics, 2013-2018
Revenue and Net Income of Beijing Strong Biotechnologies, 2013-2018
Revenue Structure of Beijing Strong Biotechnologies by Product, 2013-2018
Gross Margin of Beijing Strong Biotechnologies, 2013-2018
IVD Revenue of Beijing Strong Biotechnologies, 2013-2018
Revenue and Net Income of MedicalSystem Biotechnology, 2013-2018
Revenue Structure of MedicalSystem Biotechnology by Product, 2013-2018
Gross Margin of MedicalSystem Biotechnology, 2013-2018
IVD Revenue of MedicalSystem Biotechnology, 2013-2018
Revenue and Net Income of DAAN Gene, 2013-2018
Revenue Structure of DAAN Gene by Product, 2013-2018
Gross Margin of DAAN Gene, 2013-2018
IVD Revenue of DAAN Gene, 2013-2018
Revenue and Net Income of Beijing Leadman Biochemistry, 2013-2018
Revenue Structure of Beijing Leadman Biochemistry by Product, 2013-2018
Gross Margin of Beijing Leadman Biochemistry, 2013-2018
IVD Revenue of Beijing Leadman Biochemistry, 2013-2018
Revenue and Net Income of Sinocare, 2013-2018
Revenue Structure of Sinocare by Product, 2013-2018
Gross Margin of Sinocare, 2013-2018
IVD Revenue of Sinocare, 2013-2018
Revenue and Net Income of Shanghai Kehua Bio-Engineering, 2013-2018
Revenue Structure of Shanghai Kehua Bio-Engineering by Product, 2013-2018
Gross Margin of Shanghai Kehua Bio-Engineering, 2013-2018
IVD Revenue of Shanghai Kehua Bio-Engineering, 2013-2018
Revenue and Net Income of Shanghai Fosun Pharmaceutical, 2013-2018
Revenue Structure of Shanghai Fosun Pharmaceutical by Product, 2013-2018
Gross Margin of Shanghai Fosun Pharmaceutical, 2013-2018
IVD Revenue of Shanghai Fosun Pharmaceutical, 2013-2018
Revenue and Net Income of Livzon Pharmaceutical Group, 2013-2018
Revenue Structure of Livzon Pharmaceutical Group by Product, 2013-2018
Gross Margin of Livzon Pharmaceutical Group, 2013-2018
IVD Revenue of Livzon Pharmaceutical Group, 2013-2018
Revenue and Net Income of Maccura Biotechnology, 2013-2018
Revenue Structure of Maccura Biotechnology by Product, 2013-2018
Gross Margin of Maccura Biotechnology, 2013-2018
IVD Revenue of Maccura Biotechnology, 2013-2018
Revenue and Net Income of Guangzhou Wondfo Biotech, 2013-2018
Revenue Structure of Guangzhou Wondfo Biotech by Product, 2013-2018
Gross Margin of Guangzhou Wondfo Biotech, 2013-2018
IVD Revenue of Guangzhou Wondfo Biotech, 2013-2018
Revenue and Net Income of Biosino Bio-Technology and Science, 2013-2018
Revenue Structure of Biosino Bio-Technology and Science by Product, 2013-2018
Gross Margin of Biosino Bio-Technology and Science, 2013-2018
IVD Revenue of Biosino Bio-Technology and Science, 2013-2018
Revenue and Net Income of Jiangsu Bioperfectus Technologies, 2013-2018
Revenue Structure of Jiangsu Bioperfectus Technologies by Product, 2013-2018
Gross Margin of Jiangsu Bioperfectus Technologies, 2013-2018
IVD Revenue of Jiangsu Bioperfectus Technologies, 2013-2018
Revenue and Net Income of Zhejiang Orient Gene Biotech, 2013-2018
Revenue Structure of Zhejiang Orient Gene Biotech by Product, 2013-2018
Gross Margin of Zhejiang Orient Gene Biotech, 2013-2018
IVD Revenue of Zhejiang Orient Gene Biotech, 2013-2018
Revenue and Net Income of HOB Biotech Group Suzhou, 2013-2018
Revenue Structure of HOB Biotech Group Suzhou by Product, 2013-2018
Gross Margin of HOB Biotech Group Suzhou, 2013-2018
IVD Revenue of HOB Biotech Group Suzhou, 2013-2018
Revenue and Net Income of Lifotronic Technology, 2013-2018
Revenue Structure of Lifotronic Technology by Product, 2013-2018
Gross Margin of Lifotronic Technology, 2013-2018
IVD Revenue of Lifotronic Technology, 2013-2018
Revenue and Net Income of Hotgen Biotech, 2013-2018
Revenue Structure of Hotgen Biotech by Product, 2013-2018
Gross Margin of Hotgen Biotech, 2013-2018
IVD Revenue of Hotgen Biotech, 2013-2018
Revenue and Net Income of Dirui Industrial, 2013-2018
Revenue Structure of Dirui Industrial by Product, 2013-2018
Gross Margin of Dirui Industrial, 2013-2018
IVD Revenue of Dirui Industrial, 2013-2018
Revenue and Net Income of Getein Biotech, 2013-2018
Revenue Structure of Getein Biotech by Product, 2013-2018
Gross Margin of Getein Biotech, 2013-2018
IVD Revenue of Getein Biotech, 2013-2018
Revenue and Net Income of Guangdong Hybribio Biotech, 2013-2018
Revenue Structure of Guangdong Hybribio Biotech by Product, 2013-2018
Gross Margin of Guangdong Hybribio Biotech, 2013-2018
IVD Revenue of Guangdong Hybribio Biotech, 2013-2018
Revenue and Net Income of Beijing Bohui Innovation Biotechnology, 2013-2018
Revenue Structure of Beijing Bohui Innovation Biotechnology by Product, 2013-2018
Gross Margin of Beijing Bohui Innovation Biotechnology, 2013-2018
IVD Revenue of Beijing Bohui Innovation Biotechnology, 2013-2018
Revenue and Net Income of Edan Instruments, 2013-2018
Revenue Structure of Edan Instruments by Product, 2013-2018
Gross Margin of Edan Instruments, 2013-2018
IVD Revenue of Edan Instruments, 2013-2018
Revenue and Net Income of Wuhan Easy Diagnosis Biomedicine, 2013-2018
Revenue Structure of Wuhan Easy Diagnosis Biomedicine by Product, 2013-2018
Gross Margin of Wuhan Easy Diagnosis Biomedicine, 2013-2018
IVD Revenue of Wuhan Easy Diagnosis Biomedicine, 2013-2018

  • Global (United States, European Union and China) Female Fertility and Pregnancy Rapid Test Market Research Report 2019-2025
    Published: 14-Aug-2019        Price: US 3280 Onwards        Pages: 117
    The retail stores include drugstores, supermarkets, and hypermarkets. The demand for female fertility and pregnancy rapid tests is high due to the wide presence of retail stores. In developing countries such as India, especially the rural areas, people prefer retail stores to purchase medical products such as pregnancy test kit and female fertility kits because they have limited feasibility to purchase products online. This in turn, will have a positive impact on the female fertility and pregnan......
  • Global Infectious Disease Testing Industry Market Research Report
    Published: 13-Aug-2019        Price: US 2960 Onwards        Pages: 125
    The Infectious Disease Testing market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Infectious Disease Testing industrial chain, this report mainly elaborates the definition, types, applications and major players of Infectious Disease Testing market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterp......
  • Global Respiratory Disease Testing Industry Market Research Report
    Published: 13-Aug-2019        Price: US 2960 Onwards        Pages: 105
    The Respiratory Disease Testing market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Respiratory Disease Testing industrial chain, this report mainly elaborates the definition, types, applications and major players of Respiratory Disease Testing market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of ent......
  • Global (United States, European Union and China) D-dimer Testing Market Research Report 2019-2025
    Published: 12-Aug-2019        Price: US 3280 Onwards        Pages: 116
    D-dimer tests are used for diagnosing conditions related broadly to deep vein thrombosis (DVT), pulmonary embolism, and disseminated intravascular coagulation (DIC). In 2019, the market size of D-dimer Testing is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been co......
  • Global and China In-Vitro Diagnostics (IVD) Market Research by Company, Type & Application 2013-2025
    Published: 12-Aug-2019        Price: US 2000 Onwards        Pages: 64
    Summary In-Vitro Diagnostics (IVD) is test that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home. Market Segment as follows: By Type - Test equipment - Test Reagents By Application - Endocrine examination - Tumor detection - Infectious disease detection - Immunoassay - Others......
  • Global In-Vitro Diagnostics (IVD) Market Report: Insights, Trends and Forecast (2019-2023)
    Published: 10-Aug-2019        Price: US 1800 Onwards        Pages: 112
    The global IVD market value is forecasted to reach US$92.54 billion in 2023, growing at a CAGR of 6.6%, for the period spanning from 2018 to 2023. The factors such as increasing diabetic patient count, surging chronic ailments incidence, rising healthcare expenditure, growing geriatric population, accelerating economic growth and improving consumer confidence are expected to drive the market growth. However, growth of the industry would be challenged by stringent regulations and intense compe......
  • Global In Vitro Diagnostics Market: Instrumentation Review and Strategic Profiles of Leading Suppliers
    Published: 08-Aug-2019        Price: US 7500 Onwards        Pages: 370
    This new report from VPGMarketResearch.com reviews operating characteristics and features of major automated and semi-automated high-, medium-, and low-volume/POC in vitro diagnostic systems within the following market segments: -Blood Typing, Grouping, and Screening Cancer Diagnostic Clinical Chemistry and Immunodiagnostics Coagulation Testing Hematology and Flow Cytometry Microbiology Molecular DiagnosticsThe report also presents st......
  • Three Scenarios of the Future In Vitro Diagnostics Market: Business-as-Usual, Economic Austerity, Technological Breakthroughs
    Published: 08-Aug-2019        Price: US 9500 Onwards        Pages: 255
    This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include: To identify and evaluate emerging markets and Technologies that may present unexpected threats or offer opportunities. To identify key strategic decisions that will have to be made in the future. To enhance corporate ability to develop realistic contingency plans. To pre......
  • US In Vitro Diagnostics Forecasts for 500 Tests, 2019-2023: Supplier Shares by Test, Segment Volume and Sales Forecasts, Instrumentation Review, Opportunities for Suppliers
    Published: 07-Aug-2019        Price: US 3500 Onwards        Pages: 101
    This new report from LeadingMarketResearch.com provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments:......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs